English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Plus monthly

Global: Zendy Tools annual

Global: Zendy Tools monthly

Global: Zendy Free Plan

The Global Initiative for Chronic Obstructive Lung Disease (GOLD) advocates a combined assessment of chronic obstructive pulmonary disease using lung function, symptoms, and exacerbation history to categorise patients into group A, B, C, or D. The aims of treatment are to reduce symptoms and prevent future risk, with the choice of treatment tailored according to the category. GOLD promotes an individualised approach to treatment. This review appraises the strengths and potential weaknesses of the current GOLD recommendations for combined assessment and pharmacological treatment of stable chronic obstructive pulmonary disease. There have been a number of recent publications applying the GOLD classification system to different chronic obstructive pulmonary disease populations. What can be learnt from these papers is reviewed, as well as the evidence base for the GOLD recommendations for pharmacological therapy. (BRN Rev. 2016;2:27-39) Corresponding author: Dave Singh, DSingh@meu.org.uk

barcelona respiratory network reviews

Management of Chronic Obstructive Pulmonary Disease: A Personalized Interpretation of the Global Initiative for Chronic Obstructive Lung Disease (GOLD) - ABCD Recommendations